Altimmune to Present at Upcoming H.C. Wainwright Investor Conferences October 12-13, 2021

Rhea-AI Summary

Altimmune, a clinical-stage biopharmaceutical company, has announced that its management will present virtually at two upcoming H.C. Wainwright Investor Conferences. The presentations include the 5th Annual NASH Investor Conference on October 12, 2021 at 3:30 PM ET, and the Hepatitis B Virus Virtual Conference on October 13, 2021 at 4:30 PM ET. Interested individuals can access the sessions via the Events section on Altimmune's website.

Altimmune focuses on developing treatments for obesity and liver diseases, with key products including next-generation peptide therapeutics.

GAITHERSBURG, Md., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the management team will be presenting virtually at the following H.C. Wainwright Investor Conferences:

• H.C. Wainwright 5^th Annual NASH Investor Conference
  Tuesday, October 12, 2021
  3:30 pm Eastern Time

• H.C. Wainwright Hepatitis B Virus (HBV) Virtual Conference
  Wednesday, October 13, 2021
  4:30 pm Eastern Time

The sessions will be webcast and can be accessed by visiting the Events section of the Altimmune website.

About Altimmune

Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Our pipeline includes next generation peptide therapeutics for obesity, NASH (pemvidutide), and chronic hepatitis B (HepTcell™).   For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Investor & Media Contacts:

Will Brown
Chief Financial Officer
Phone: 240-654-1450
wbrown@altimmune.com

FAQ

What are the dates of Altimmune's presentations at the H.C. Wainwright conferences?

Altimmune will present on October 12, 2021, and October 13, 2021.

At what time will Altimmune present at the H.C. Wainwright 5th Annual NASH Investor Conference?

Altimmune's presentation at the NASH Investor Conference is scheduled for 3:30 PM ET on October 12, 2021.

When is the Hepatitis B Virus Virtual Conference taking place?

The Hepatitis B Virus Virtual Conference will take place on October 13, 2021, at 4:30 PM ET.

How can I access Altimmune's presentations at the H.C. Wainwright conferences?

You can access the presentations through the Events section on Altimmune’s website.

What is Altimmune's focus area in biopharmaceutical development?

Altimmune focuses on developing treatments for obesity and liver diseases.